Log in to your Inderes Free account to see all free content on this page.

Genovis

19.40 SEK

+2.54%

1,631 following

GENO

First North Stockholm

Biotechnology & Pharmaceuticals

Health Care

Quarter data

Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Genovis

Q4/242024Q1/25Q2/25Q3/25Q4/252025Q1/26
Revenue27.9130.432.328.927.540.3128.933.5
EBITDA7.856.28.96.06.911.733.69.5
EBIT5.345.76.43.53.48.121.35.8
EBIT-%19.1 %35.1 %19.8 %12.0 %12.3 %20.0 %16.5 %17.2 %
Profit before taxes5.646.36.13.79.37.726.85.5
Net income4.632.93.55.18.06.923.54.3
Login required

This content is only available for logged in users